drugset / Trial / NCT03998423

Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease

NCT03998423

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to assess the safety and feasibility of an oral fecal microbiota transplant (FMT) intervention for Alzheimer's disease (AD).

Timeline

Start
2019-11-14
Primary completion
2020-07-14
Completion
2020-07-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplant Other / unclassified 22.5 g Oral

Indications